Literature DB >> 31449475

Examining Physician Interactions with Disease Advocacy Organizations.

Caroline Horrow1, Joel E Pacyna1, Carol Cosenza2, Richard R Sharp3.   

Abstract

Disease advocacy organizations (DAOs) have traditionally focused on raising awareness of rare diseases, providing educational resources to patients, and supporting patients and families. Previous research has described how scientists collaborate with DAOs, but few empirical data are available regarding the extent to which physicians interact with DAOs and how those interactions impact patient care. We conducted a national survey of 230 board-certified pediatric neurologists to assess their engagement with DAOs and their beliefs about the impact of DAOs on patient care. In that context, we evaluated a set of 24 items describing interactions between physicians and DAOs. Exploratory factor analysis produced a 19-item model capturing four types of physician-DAO engagement: (1) accessing or distributing DAO-produced materials (6 items, alpha = 0.80); (2) consulting on DAO activities (5 items, alpha = 0.81); (3) collaborating with DAOs on research activities (6 items, alpha = 0.80); and (4) co-producing scholarly materials with DAOs (2 items, alpha = 0.80). Our data indicate that physicians engage with DAOs in more frequent and diverse ways than has been previously reported. Almost all physicians in our sample had interacted directly with a DAO in some way, from low-effort activities such as visiting a DAO's website to deeper forms of engagement including coauthoring journal articles. These findings may provide a framework for bioethicists to characterize the nature and extent of physician interactions with advocacy organizations, which is critical for evaluating the ethical implications of physician-DAO relationships.

Entities:  

Keywords:  Bioethics; quantitative research; social science; survey

Mesh:

Year:  2019        PMID: 31449475      PMCID: PMC7259376          DOI: 10.1080/23294515.2019.1652213

Source DB:  PubMed          Journal:  AJOB Empir Bioeth        ISSN: 2329-4515


  28 in total

1.  Physician-citizens--public roles and professional obligations.

Authors:  Russell L Gruen; Steven D Pearson; Troyen A Brennan
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

2.  Younger physicians, specialists use Internet more.

Authors:  Shelley Martin
Journal:  CMAJ       Date:  2004-06-08       Impact factor: 8.262

3.  The role of patient advocacy/parent support groups.

Authors:  Judith G Hall
Journal:  S Afr Med J       Date:  2013-10-11

Review 4.  Rare disease patient groups as clinical researchers.

Authors:  Ginger R Polich
Journal:  Drug Discov Today       Date:  2011-10-12       Impact factor: 7.851

5.  Generating sociability to drive science: patient advocacy organizations and genetics research.

Authors:  Aaron Panofsky
Journal:  Soc Stud Sci       Date:  2011-02       Impact factor: 3.885

Review 6.  A literature review and meta-analysis of drug company-funded mental health websites.

Authors:  J Read; A Cain
Journal:  Acta Psychiatr Scand       Date:  2013-05-10       Impact factor: 6.392

7.  Multifaceted roles of ultra-rare and rare disease patients/parents in drug discovery.

Authors:  Jill Wood; Lori Sames; Allison Moore; Sean Ekins
Journal:  Drug Discov Today       Date:  2013-08-19       Impact factor: 7.851

8.  Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.

Authors:  Susannah L Rose
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718

9.  How disease advocacy organizations participate in clinical research: a survey of genetic organizations.

Authors:  David C Landy; Margaret A Brinich; Mary Ellen Colten; Elizabeth J Horn; Sharon F Terry; Richard R Sharp
Journal:  Genet Med       Date:  2012-02       Impact factor: 8.822

10.  Rare Diseases on the Internet: An Assessment of the Quality of Online Information.

Authors:  Frédéric Pauer; Svenja Litzkendorf; Jens Göbel; Holger Storf; Jan Zeidler; Johann-Matthias Graf von der Schulenburg
Journal:  J Med Internet Res       Date:  2017-01-18       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.